ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Animal models"

  • Abstract Number: 566 • 2013 ACR/ARHP Annual Meeting

    A Human Monoclonal Antibody Against Domain I Of β2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models

    Chiara Agostinis1, Paolo Durigutto2, Daniele Sblattero2, Maria Orietta Borghi3,4, Claudia Grossi4, Roberta Bulla2, Paolo Macor2, Pier Luigi Meroni3,5 and Francesco Tedesco2, 1Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy, 2Department of Life Sciences, University of Trieste, Trieste, Italy, 3Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, 4Laboratory of Immuno-rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy, 5Department of Clinical Sciences and Community Health, Division of Rheumatology, Istituto G. Pini, Milan, Italy

    Background/Purpose: Anticoagulant, antiplatelet or immunosuppressive therapy are currently used to treat the clinical manifestations of the anti-phospholipid syndrome (APS). Side effects or recurrences in spite…
  • Abstract Number: 2235 • 2013 ACR/ARHP Annual Meeting

    Fas Signaling In Macrophages Promotes Chronicity In K/BxN Serum Transfer Induced Arthritis

    Qi Quan Huang1, Robert Birkett2, Renee E. Koessler1, Carla M. Cuda3, J.-P. Jin4, Harris R. Perlman5 and Richard M. Pope6, 1Medicine/Rheumatology, Northwestern University, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL, 3Medicine / Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Physiology, Wayne State University, Detroit, MI, 5Northwestern University Feinberg School of Medicine, Chicago, IL, 6Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose: A non-apoptotic role for Fas signaling has been implicated in the regulation of inflammation and innate immunity.  These studies were performed to elucidate the…
  • Abstract Number: 1281 • 2013 ACR/ARHP Annual Meeting

    Inadequate Glucocorticoid Secretion in Experimental Arthritis in Rats Is Closely Linked to Impaired Mitochondria and Reduced Lipid Breakdown in the Adrenal Cortex

    Christine Wolff1, Katharina Krinner1, Josef Schröder2 and Rainer H. Straub3, 1Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, Department of Internal Medicine I, University Hospital, Regensburg, Germany, 2Department of Phatology, University Hospital, Regensburg, Germany, 3Department of Internal Medicine I, Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, University Hospital of Regensburg, Regensburg, Germany

    Background/Purpose: In rheumatoid arthritis a functional deterioration of the HPA-axis in form of inadequately low secretion of glucocorticoids in relation to severity of inflammation can…
  • Abstract Number: 542 • 2013 ACR/ARHP Annual Meeting

    Evidence For Involvement Of C5a Receptor in Human and Murine Lupus Nephritis

    Constanze Hess1, Ditte Tornehave2, Peter Helding Kvist2, Yvonne Sundström3, Louise Berg3, Iva Gunnarsson4, Søren Jacobsen5, Claus Haase1 and Lars Hornum1, 1Department of Immunopharmacology, Novo Nordisk A/S, Måløv, Denmark, 2Department of Histology, Novo Nordisk A/S, Måløv, Denmark, 3Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 4Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 5Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    Background/Purpose: The complement system plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Apart from the activation of the early components of…
  • Abstract Number: 2236 • 2013 ACR/ARHP Annual Meeting

    Articular Inflammation Is Protected By Fat-1 During The Acute Phase Of Arthritis In Mice

    Sang-Il Lee1, Yun-Hong Cheon2, Ji-Min Kim3 and Won Seok Lee2, 1Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 2Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

    Background/Purpose: Omega-3 polyunsaturated fatty acids (n-3 PUFA) are well known to exert anti-inflammatory effects. The Fat-1 transgenic (Fat-1 TG) mice are capable of producing n-3…
  • Abstract Number: 1285 • 2013 ACR/ARHP Annual Meeting

    Choline Kinase: A Novel Target For Rheumatoid Arthritis

    Monica Guma1, Elsa Sanchez-Lopez2, Alessia Lodi3, Stefano Tiziani4, Juan Carlos Lacal5, Michael Karin6 and Gary S. Firestein7, 1Rheumatology, UCSD School of Medicine, La Jolla, CA, 2Pharmacology, UCSD School of Medicine, La Jolla, CA, 3nutritional Sciences, University of Texas at Austin, Austin, TX, 4Nutritional Sciences, University of Texas at Austin, Austin, TX, 5Oncology, University Hospital Fundacion Jimenez Diaz, Madrid, Spain, 6Departments of Pharmacology, UCSD School of Medicine, La Jolla, CA, 7Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose: Choline kinase (ChoKa) is an essential enzyme for phosphatidylcholine biosynthesis and is required for cell proliferation. The enzyme has also been implicated in cancer…
  • Abstract Number: 553 • 2013 ACR/ARHP Annual Meeting

    Estrogen Receptor Alpha Deficiency Protects Against Development Of Cognitive Impairment In Murine Lupus

    Melissa A. Cunningham1, Jena Wirth1, Heather A. Boger2, Ann-Charlotte Granholm-Bentley3 and Gary S. Gilkeson4, 1Med/Rheumatology, MUSC, Charleston, SC, 2Neuroscience, Medical University of SC, Charleston, SC, 3Neuroscience, MUSC, Charleston, SC, 4Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Up to 80% of SLE patients have cognitive defects or affective disorders. The mechanism of CNS injury responsible for cognitive impairment is unknown.  Anti-dsDNA…
  • Abstract Number: 146 • 2013 ACR/ARHP Annual Meeting

    The Arthritis Severity Locus Cia4 Is An Early Regulator of IL-6, IL-1β, and NFκB activators’ Expression in Pristane-Induced Arthritis

    Max Brenner1,2, Teresina Laragione1,2 and Percio Gulko1,2, 1Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 2Molecular Medicine, Hosftra North Shore-LIJ School of Medicine, Manhasset, NY

    Background/Purpose: Cia4 is a quantitative trait locus on rat chromosome 7 that regulates disease severity and joint damage in three models of rheumatoid arthritis including…
  • Abstract Number: 2214 • 2013 ACR/ARHP Annual Meeting

    STAT3 Blockade Suppresses Autoimmune Arthritis In Mice Via The Reciprocal Regulation Of Treg and Th17 Cells

    Jennifer Lee1, Jae Ho Lee1, Seung Min Jung2, Young Sun Suh1, Jung Hee Koh1, Soo Young Lee3, Dae Chul Jeong4, Mi-La Cho5, Seung-Ki Kwok1, Ji Hyeon Ju1, Kyung-Su Park1 and Sung-Hwan Park6, 1Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 3Department of Pediatrics, School of Medicine, The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, South Korea, 4Division of Rheumatology, Department of Pediatrics, School of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea, 5Rheumatism Research Center, Catholic Research Institute of Medical Science, Catholic University of Korea, Seoul, South Korea, 6Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea

    Background/Purpose: IL-6-mediated STAT3 signaling which is essential to Th17 differentiation plays the central role in the pathogenesis of rheumatoid arthritis. To investigate the molecular mechanism…
  • Abstract Number: 1287 • 2013 ACR/ARHP Annual Meeting

    Pre-Clinical Proof-Of-Concept Of ALX-0761, a Nanobody® Neutralizing Both IL-17A and F In a Cynomolgus Monkey Collagen Induced Arthritis Model

    Katrien Vanheusden1, Laurent Detalle1, Alex Hemeryck1, Alain Vicari2, Roland Grenningloh3, Sofie Poelmans1, Heidi Wouters4 and Thomas Stöhr1, 1Pharmacology, Ablynx NV, Gent, Belgium, 2Calypso Biotech, Geneva, Switzerland, 3Pharmacology, Merck-Serono, Darmstadt, Germany, 4Clinical Development, Ablynx nv, Zwijnaarde, Belgium

    Background/Purpose: Interleukin (IL)-17 and Th17 cells are implicated in many auto-immune diseases, such as rheumatoid arthritis (RA), psoriasis and multiple sclerosis. Although IL-17(A) is the…
  • Abstract Number: 559 • 2013 ACR/ARHP Annual Meeting

    Effects Of In Vivo Treatment With Hydroxychloroquine On Endothelial Function In a Murine Model Of Systemic Lupus Erythematosus

    Marta Mosca1, Chiara Tani2, Sabrina Vagnani3, Linda Carli3,4, Rosaria Talarico5, Chiara Baldini5, Stefano Bombardieri3 and Agostino Virdis6, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 3Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 4GenOMeC PhD, University of Siena, Siena, Italy, 5University of Pisa, Rheumatology Unit, Pisa, Italy, 6Department of Clinical and Experimental Medicine. University of Pisa, Hypertension Unit, University of Pisa, Pisa, Italy

    Background/Purpose: Antimalarial drugs are a cornerstone of treatment of systemic lupus erythematosus (SLE). It has been suggested that antimalarial drugs may have a protective effect…
  • Abstract Number: 148 • 2013 ACR/ARHP Annual Meeting

    Microarray Analysis Of  Synovial Specimen of Early Human (CHECK) and Experimental Osteoarthritis to Identify Pathways and Processes Associated with Pathology

    Arjen B. Blom1, Peter L. van Lent2, Martijn H. van den Bosch1, Hans Cats3, Frank H.J. van den Hoogen4, Peter M. van der Kraan5 and Wim B. van den Berg6, 1Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology Research & Advanced Therpeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology, Rheumatology Centre Sint Maartenskliniek, Nijmegen, Netherlands, 4Rheumatology, Rheumatology Centre Sint Maartenskliniek and Radboud university medical center, Ubbergen (Nijmegen), Netherlands, 5Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 6Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: The majority of osteoarthritis (OA) patients show synovial inflammation, even relatively early during the disease. We used microarray analysis of synovial tissue of early…
  • Abstract Number: 2215 • 2013 ACR/ARHP Annual Meeting

    Apoptotic Cell-Based Therapy To Treat Collagen-Induced Experimental Arthritis. Rationale For The Use Of Apoptotic Cells In The Treatment Of Rheumatoid Arthritis

    Sylvain Perruche1, Amandine Clauzon1, Francis Bonnefoy1, Eric Toussirot2 and Philippe Saas3, 1UMR1098 INSERM, EFS Bourgogne Franche Comté, Besançon, France, 2Université de Franche Comté , CHRU, CIC Biotherapy 506 and Rheumatology and EA 4266 Pathogens and Inflammation, Besançon, France, 3Etablisement Français du Sang ; Université de Franche Comté, INSERM UMR1098, Besançon, France

    Background/Purpose: Most of the currently available biological agents used in the treatment of rheumatoid arthritis (RA) target a cellular or soluble factor involved in the…
  • Abstract Number: 1294 • 2013 ACR/ARHP Annual Meeting

    Anti-Inflammatory Effect Of Resveratrol As a Dietary Supplement In An Antigen-Induced Arthritis Rat Model

    Romina R. Riveiro-Naveira1, Jesus Loureiro1, Alberto Centeno-Cortés2, Eduardo López-Peláez2, Carlos Vaamonde-García1, M. Noa Valcárcel-Ares1, Francisco J. Blanco3 and Maria J. López-Armada1, 1Aging and Inflammation Research Lab, INIBIC-CHU A Coruña, A Coruña, Spain, 2Experimental Surgery Unit, CHU A Coruña, A Coruña, Spain, 3Osteoarticular and Aging Research Laboratory, Proteomics Unit-Associated Node to ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña, Spain

    Background/Purpose: Inflammatory cells like macrophages, lymphocytes and neutrophils in hyperplasic synovial tissue have been identified as key players in the onset and development of rheumatoid…
  • Abstract Number: 526 • 2013 ACR/ARHP Annual Meeting

    Endochondral Bone Formation and Advanced Enthesitis Are Key Features Of Proteoglycan Induced Spondylitis Mouse Model Of Ankylosing Spondylitis

    Gethin P Thomas1, Hsu-Wen Tseng2, Allison Pettit3,4, Tibor T. Glant5, Allan McRae2 and Matthew A. Brown6, 1Translational Reserch Institute, University of Queensland Diamantina Institute, Woolloongabba, Australia, 2University of Queensland Diamantina Institute, Woolloongabba, Australia, 3Mater Research, Woolloongabba, Australia, 4University of Queensland Centre for Clinical Research, Herston, Australia, 5Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 6University of Queensland Diamantina Institute, Brisbane, Australia

    Background/Purpose: Transition from an initial inflammatory phase to the disabling osteoproliferative phase in ankylosing spondylitis (AS) is very poorly understood. Elucidation of the mechanisms underlying…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology